India Diagnostic Laboratories Market Report 2025-2030: Digital Innovation and Personalized Care Transform the Landscape

Yahoo

26-05-2025

India's diagnostic laboratory market is on a growth trajectory, fueled by rising healthcare awareness, technological advancements, and chronic disease prevalence. Valued at INR 1.54 Trn in FY 2024, it is expected to reach INR 2.98 Trn by FY 2030, with a CAGR of ~11.70%. Key drivers include government incentives like the PLI scheme, increased foreign investments, and the growing demand for preventative healthcare. The market comprises pathology and radiology segments, with significant contributions from In Vitro Diagnostics (IVD). Additionally, advancements in digital imaging and AI-driven diagnostics are enhancing service accessibility, particularly in rural areas.
Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Diagnostic Laboratories Market in India (2025 - 2030)" report has been added to ResearchAndMarkets.com's offering.The diagnostic laboratories market in India was valued at INR 1.54 Trn in FY 2024. It is expected to reach INR 2.98 Trn by FY 2030, expanding at a compound annual growth rate (CAGR) of ~11.70% during the FY 2025 - FY 2030 period.
India's diagnostic laboratory market is poised for substantial growth, driven by rising healthcare awareness, technological advancements, and a growing burden of chronic diseases. The sector is a key component of the healthcare system, facilitating early disease detection and treatment planning. Government initiatives such as the Production Linked Incentive (PLI) scheme and increased foreign investments are expected to further boost this market. The industry is seeing rapid digitization, enhancing accessibility to quality diagnostic services across both urban and rural areas.Factors such as an aging population, increased disposable income, and the shift towards preventive healthcare are fueling growth. The sector comprises both standalone laboratories and hospital-based diagnostic centers, with In Vitro Diagnostics (IVD) playing a crucial role in market expansion. The government's push for local manufacturing, coupled with the PLI 2.0 scheme, aims to enhance domestic production capabilities. India is also a leading hub for medical tourism, contributing to the rising demand for high-quality diagnostics.Market segmentation:India's diagnostic laboratories market comprises two segments: pathology and radiology Pathology services, including biochemistry, hematology, and microbiology, dominate the market. The IVD sector, covering RT-PCR, ELISA, and molecular diagnostics, is projected to grow significantly due to increasing demand for early disease detection.
The radiology segment, covering X-rays, MRI, CT scans, and ultrasound, is witnessing technological advancements. Digital imaging and AI-powered diagnostics are streamlining operations. The Make in India initiative has encouraged domestic manufacturing of high-end imaging equipment, reducing dependency on imports. Tele-radiology services are gaining traction, allowing specialists to analyze scans remotely, particularly in rural areas.Market trends:The Indian diagnostic laboratories market is undergoing significant transformation, driven by the adoption of digital technologies and a shift towards personalized healthcare. The rise of AI-powered diagnostics, cloud-based platforms, and wearable technology is enhancing test accuracy, speed, and accessibility. Preventive healthcare is gaining traction, with increasing demand for genetic testing, early cancer screening, and wellness packages.
Government and private investments, including the PLI scheme and FDI policies, are fostering local manufacturing of diagnostic equipment, reducing reliance on imports and lowering costs. Point-of-care (POC) testing is expanding, providing quick, cost-effective diagnostics in remote areas, while home-based testing is becoming mainstream, supported by mobile sample collection and AI-driven analysis. These trends are collectively shaping a more efficient and patient-centric diagnostic ecosystem in India.Key Topics Covered: Chapter 1: Executive SummaryChapter 2: Socio-economic IndicatorsChapter 3: Introduction3.1. Market Definition and StructureChapter 4: Market Overview4.1. India Diagnostic Laboratories Market Overview4.1.1. Market Size and Growth Forecast Based on Value (FY 2022 - FY 2030e)4.2. India Diagnostic Laboratories Market Segmentation -Based on Diagnostic Test Type4.3. Region-wise Labs Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL)4.4. Regulatory Bodies of Diagnostics Labs Market in India4.5. Distribution of Diagnostics Labs in India (FY 2023)Chapter 5: Market Segmentation5.1. India Diagnostic Laboratories Market Segmentation - Based on Diagnostic Test Type5.2. Pathology Market Size and Growth Forecast (FY2022 - FY2030e)5.3. Radiology Market Size and Growth Forecast (FY 2022 - FY 2030e)Chapter 6: Market Influencers6.1. Market Drivers6.2. Market ChallengesChapter 7: Market Trends7.1. Key Market TrendsChapter 8: Government Initiatives8.1. Favorable Government InitiativesChapter 9: Competitive landscape9.1. Dr. Lal Pathlabs Limited
Company information
Business description
Products/Services
Key people
Financial snapshot
Key ratios
Key financial performance indicators
Key business segments
Key geographic segments
Note: Financial information has been covered only for public companies.9.2. Metropolis Healthcare Limited9.3. Suraksha Diagnostic Limited9.4. Thyrocare Technologies Limited9.5. Vijaya Diagnostic Centre Limited9.6. Agilus Diagnostics Limited9.7. Apollo Diagnostics9.8. MEDall Healthcare Private Limited9.9. RedCliffe LabsChapter 10: Recent developments
For more information about this report visit https://www.researchandmarkets.com/r/9mrn5f
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [e-mail] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call [phone]